Yajin Chen
3PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.Ningning Zhang, Tian Liu, Ming Luo
|May 12, 2025
Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.Hongkai Zhuang, Chenwei Tang, Wentao Wang
|Apr 30, 2024
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.Yajin Chen, Chengyou Du, Shunli Shen
Pageof 1
Frequent Collaborators
2 joint publications
Changzhen Shang
1 joint publications
Chengyou Du
1 joint publications
Shunli Shen
1 joint publications
Wu Zhang
1 joint publications
Yunfeng Shan
1 joint publications
Ang Lyu
1 joint publications
Jianhui Wu
1 joint publications
Xuan Luo
1 joint publications
Jinxing Wei
1 joint publications
Heng Xiao
